Medtronic(Minneapolis) blew analysts' expectations out of the water in the latter part of May when it reported its 4Q financial results, based for the most part on the results of the initial sales of its new Endeavor drug-eluting stent (DES).

Business developments: Street's expectations topped by Medtronic via Endeavor launch

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR